Search

See all results

417 Result(s)

Grass Roots

How Boehringer Ingelheim is Supporting Grass Roots Innovation

Our Grass Roots activities support life-science innovators with mentoring and networking opportunities.

Grass Roots

How We Support Grass Roots Innovation

Hear from life-science entrepreneurs about how we are supporting early-stage science through our innovative Grass Roots program.

Human Health Partnering

Our Grass Roots Innovation Program

Learn about our Grass Roots activities that support life-science innovators and entrepreneurs around the world

Grass Roots

About Our Innovation Prize

Find out more about how we’re providing valuable resources to life-science innovators to enable new and emerging science

Grass Roots

Celebrating Our Innovation Prize Winners

Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health

Meet our team

How collaboration is driving innovation at Boehringer Ingelheim Animal Health

In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.

Human Health Innovation

Our Innovation Strategy: how we approach research and development

Disease never rests. So neither do we. Learn about how we are driving innovation in research and development, with the patient at the core of everything with do.

Collage of a picture of a man and a woman with a video play button

Animal Health Partnering

Partnering for innovation in animal health

Collaboration with external partners is a fundamental part of the innovation strategy in our Animal Health business. Learn more about the partners we are looking for.

Dr. Chris Silali (Geneplus) and Emilian Popa (Ilara Health) during the MMH Together 2023

More Potential

Supporting social innovators is a promising approach to drive sustainable health solutions in underserved communities. Meet Geneplus, a healthcare technology company which was accepted into Making More Health’s (MMH) “Rising Stars” program.

BRASS, a software advancing patient safety

Human Health Innovation

Digital innovation: “Our digital pipeline is only growing”

BRASS, a software advancing patient safety and developed fully in-house, has been sold. This is proof: our digital innovations are in demand.

Carinne Brouillon, Member of the Board of Managing Directors, at the World Health Summit 2022 in Berlin

More Health: For People & Animals

Tackling NCDs through innovation AND collaboration

Non-communicable diseases are a significant medical, humanitarian and socio-economic issue. Rapid innovation and holistic approaches help us tackle them.

Article

Excellence in innovation | Bioxcellence | Boehringer Ingelheim

History

History (1990-2023): Value through Innovation

Join us on the way towards the new millennium and learn more about the latest discoveries and developments since then.

Photo of the Innovation Prize certificate

Article

Boehringer Ingelheim Innovation Prize

Watch our video to see our BD&L team, along with Glennis Mehra, Director of BioLabs, talk about championing innovation and how the Innovation Prize provides important benefits for early-stage companies.

Fostering Science

Open Innovation at Boehringer Ingelheim

Science Stories

Innovation in Medicinal Chemistry: Unlocking Unsolved Diseases

From AI to PROTACs, Darryl McConnell and Jürgen Mack explain how our teams leverage cutting-edge approaches aiming to bring ‘undruggable’ targets within reach.

Science & Innovation

Welcome to Innovation @ Boehringer Ingelheim

Find out how we’re translating new ideas and new science into breakthrough medicines at Boehringer Ingelheim.

More Potential

Many people in the U.S. face low access to fresh food. Enter Katie Plohocky, a social innovator who's making a difference to this food deserts with her Healthy Community Store Initiative.

Pulmonary Fibrosis

Hope for the future of interstitial lung disease (ILD) care

Karen Moor, pulmonologist in training and post-doctoral researcher in interstitial lung diseases (ILDs), shares her advice for aspiring pulmonologists and her hopes for the future of ILD care.